The store will not work correctly when cookies are disabled.
2-Fluoro-3-{6-[1-(4-fluoro-3-hydroxyphenyl)ethenyl]pyridin-2-yl}phenol
ID: ALA4175585
Chembl Id: CHEMBL4175585
PubChem CID: 134158354
Max Phase: Preclinical
Molecular Formula: C19H13F2NO2
Molecular Weight: 325.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: C=C(c1ccc(F)c(O)c1)c1cccc(-c2cccc(O)c2F)n1
Standard InChI: InChI=1S/C19H13F2NO2/c1-11(12-8-9-14(20)18(24)10-12)15-5-3-6-16(22-15)13-4-2-7-17(23)19(13)21/h2-10,23-24H,1H2
Standard InChI Key: LSHVGZUGKOCADJ-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 325.31 | Molecular Weight (Monoisotopic): 325.0914 | AlogP: 4.50 | #Rotatable Bonds: 3 |
Polar Surface Area: 53.35 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.89 | CX Basic pKa: 2.32 | CX LogP: 5.02 | CX LogD: 4.89 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.75 | Np Likeness Score: -0.34 |
References
1. Braun F, Bertoletti N, Möller G, Adamski J, Frotscher M, Guragossian N, Madeira Gírio PA, Le Borgne M, Ettouati L, Falson P, Müller S, Vollmer G, Heine A, Klebe G, Marchais-Oberwinkler S.. (2018) Structure-based design and profiling of novel 17β-HSD14 inhibitors., 155 [PMID:29859505] [10.1016/j.ejmech.2018.05.029] |